AIM: The present study describes the assessment of true formation of type III collagen in different pathologies using a neo-epitope specific competitive Enzyme-linked immunosorbent assay (ELISA) towards the N-terminal propeptide of type III collagen (PRO-C3). METHODS: The monoclonal antibody was raised against the N-protease mediated cleavage site of the N-terminal propeptide of type III collagen and a competitive ELISA was developed using the selected antibody. The assay was evaluated in relation to neo-epitope specificity, technical performance, and as a marker for liver fibrosis and muscle mass using the rat carbon tetrachloride (CCl4) model and a study of immobilization induced muscle loss in humans, respectively. RESULTS: The ELISA was neo-epitope specific, technically stable and can be assessed in serum and plasma samples. In the CCl4 liver fibrosis model it was observed that serum PRO-C3 were significantly elevated in rats with liver fibrosis as seen by histology (56% elevated in the highest quartile of total hepatic collagen compared to control rats, p<0.001) and correlated significantly to total hepatic collagen in the diseased rats (r=0.46, p<0.01) and not in control rats, suggesting the pathological origin of the epitope. Human plasma PRO-C3 correlated significantly to muscle mass at baseline (R(2)=0.44, p=0.036). CONCLUSION: The developed neo-epitope specific serum ELISA for type III procollagen (PRO-C3) reflects true formation as it is specific for the propeptide cleaved off the intact collagen molecule. In a clinical and in a rodent study we showed that this marker was highly related to liver fibrosis and muscle mass.
AIM: The present study describes the assessment of true formation of type III collagen in different pathologies using a neo-epitope specific competitive Enzyme-linked immunosorbent assay (ELISA) towards the N-terminal propeptide of type III collagen (PRO-C3). METHODS: The monoclonal antibody was raised against the N-protease mediated cleavage site of the N-terminal propeptide of type III collagen and a competitive ELISA was developed using the selected antibody. The assay was evaluated in relation to neo-epitope specificity, technical performance, and as a marker for liver fibrosis and muscle mass using the ratcarbon tetrachloride (CCl4) model and a study of immobilization induced muscle loss in humans, respectively. RESULTS: The ELISA was neo-epitope specific, technically stable and can be assessed in serum and plasma samples. In the CCl4liver fibrosis model it was observed that serum PRO-C3 were significantly elevated in rats with liver fibrosis as seen by histology (56% elevated in the highest quartile of total hepatic collagen compared to control rats, p<0.001) and correlated significantly to total hepatic collagen in the diseased rats (r=0.46, p<0.01) and not in control rats, suggesting the pathological origin of the epitope. Human plasma PRO-C3 correlated significantly to muscle mass at baseline (R(2)=0.44, p=0.036). CONCLUSION: The developed neo-epitope specific serum ELISA for type III procollagen (PRO-C3) reflects true formation as it is specific for the propeptide cleaved off the intact collagen molecule. In a clinical and in a rodent study we showed that this marker was highly related to liver fibrosis and muscle mass.
Entities:
Keywords:
Biochemical markers; formation; liver fibrosis; muscle mass; neo-epitope; type III collagen
Authors: C Suetta; L G Hvid; L Justesen; U Christensen; K Neergaard; L Simonsen; N Ortenblad; S P Magnusson; M Kjaer; P Aagaard Journal: J Appl Physiol (1985) Date: 2009-08-06
Authors: Shalender Bhasin; E Jiaxiu He; Miwa Kawakubo; E Todd Schroeder; Kevin Yarasheski; Gregory J Opiteck; Alise Reicin; Fabian Chen; Raymond Lam; Jeffrey A Tsou; Carmen Castaneda-Sceppa; Ellen F Binder; Stanley P Azen; Fred R Sattler Journal: J Clin Endocrinol Metab Date: 2009-10-16 Impact factor: 5.958
Authors: Carine Le Goff; Robert P T Somerville; Frederic Kesteloot; Kimerly Powell; David E Birk; Alain C Colige; Suneel S Apte Journal: Development Date: 2006-04 Impact factor: 6.868
Authors: Fabian Chen; Raymond Lam; David Shaywitz; Ronald C Hendrickson; Gregory J Opiteck; Dana Wishengrad; Andy Liaw; Qinghua Song; Adrian J Stewart; Corinne E Cummings; Chan Beals; Kevin E Yarasheski; Alise Reicin; Marcella Ruddy; Xuguang Hu; Nathan A Yates; Joseph Menetski; Gary A Herman Journal: J Cachexia Sarcopenia Muscle Date: 2011-02-26 Impact factor: 12.910
Authors: Xiang Guo; Brandon W Higgs; Anne C Bay-Jensen; Morten A Karsdal; Yihong Yao; Lorin K Roskos; Wendy I White Journal: J Invest Dermatol Date: 2015-05-20 Impact factor: 8.551
Authors: Grace Huang; Guilherme V Rocha; Karol M Pencina; Karen Cox; Venkatesh Krishnan; Kim Henriksen; Peter Mitchell; Sean E Sissons; Zhuoying Li; Anders F Nedergaard; Morten A Karsdal; Shu Sun; Thomas W Storer; Shehzad Basaria; Shalender Bhasin Journal: J Clin Endocrinol Metab Date: 2019-05-23 Impact factor: 5.958
Authors: Francesca Moroni; Benjamin J Dwyer; Catriona Graham; Chloe Pass; Laura Bailey; Lisa Ritchie; Donna Mitchell; Alison Glover; Audrey Laurie; Stuart Doig; Emily Hargreaves; Alasdair R Fraser; Marc L Turner; John D M Campbell; Neil W A McGowan; Jacqueline Barry; Joanna K Moore; Peter C Hayes; Diana J Leeming; Mette J Nielsen; Kishwar Musa; Jonathan A Fallowfield; Stuart J Forbes Journal: Nat Med Date: 2019-10-07 Impact factor: 53.440
Authors: Federica Genovese; Ahmad Akhgar; Sung Sam Lim; Alton B Farris; Monica Battle; Jason Cobb; Dominic Sinibaldi; Morten A Karsdal; Wendy I White Journal: Kidney360 Date: 2021-06-18
Authors: Michele Vacca; Jack Leslie; Samuel Virtue; Brian Y H Lam; Olivier Govaere; Dina Tiniakos; Sophie Snow; Susan Davies; Kasparas Petkevicius; Zhen Tong; Vivian Peirce; Mette Juul Nielsen; Zsuzsanna Ament; Wei Li; Tomasz Kostrzewski; Diana Julie Leeming; Vlad Ratziu; Michael E D Allison; Quentin M Anstee; Julian L Griffin; Fiona Oakley; Antonio Vidal-Puig Journal: Nat Metab Date: 2020-06-08
Authors: H Jessen; N Hoyer; T S Prior; P Frederiksen; M A Karsdal; D J Leeming; E Bendstrup; J M B Sand; S B Shaker Journal: Respir Res Date: 2021-07-15